Zacks Investment Research on MSN
UiPath (PATH) stock sinks as market gains: Here's why
UiPath (PATH) closed at $14.79 in the latest trading session, marking a -3.77% move from the prior day. This change lagged ...
Zacks Investment Research on MSN
UiPath (PATH) is a great momentum stock: Should you buy?
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long ...
We recently published 10 Stocks Sparking Massive Fortunes. UiPath Inc. (NYSE:PATH) is one of the best performers on Friday. UiPath soared 34.7 percent week-on-week to hit a 19-month high, as investors ...
UiPath's stock has dropped ~20% since January, presenting a buying opportunity for long-term investors, despite macroeconomic concerns and disappointing Q4 results. UiPath focuses on agentic ...
Valued at $6.4 billion by market cap, UiPath is an enterprise-facing automation platform that offers a range of RPA (robotic process automation) solutions to clients in verticals such as banking, ...
UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback